Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × Hearing Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 1 Neoplasms 1 Hearing Loss 1

Interventions

Cyclophosphamide 851 Radiotherapy 763 Cisplatin 657 Gemcitabine 583 Docetaxel 538 Carboplatin 538 Paclitaxel 529 Bevacizumab 513 Fluorouracil 452 Rituximab 412 Oxaliplatin 405 Capecitabine 400 Surveys and Questionnaires 391 Dexamethasone 388 Doxorubicin 381 Etoposide 367 Irinotecan 351 Cytarabine 333 Filgrastim 330 pembrolizumab 277 Leucovorin 277 Melphalan 266 fludarabine phosphate 261 Magnetic Resonance Spectroscopy 259 Nivolumab 254 Blood Specimen Collection 251 Lenalidomide 244 Peripheral Blood Stem Cell Transplantation 242 Methotrexate 239 Cetuximab 236

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06036407 2025-05-30

HEAR

University of Bern

Phase NA Completed

Ototoxicity, Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡